Yildiz BO, Armeni E, Balodimou C, Biondi B, Ciudin A, Frühbeck G et al (2025) EndoBridge 2024: pearls and highlights. Horm (Athens) 24(4):923–946. https://doi.org/10.1007/s42000-025-00708-5

Article  Google Scholar 

Papazoglou AS, Leite AR, Moysidis DV et al (2024) Serum prolactin levels and mortality in adults without prolactinoma: a meta-analysis. J Clin Endocrinol Metab 109:e1652–e1664. https://doi.org/10.1210/clinem/dgae087

Article  CAS  PubMed  Google Scholar 

Ayalon-Dangur I, Shimon I, Shochat T et al (2025) Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study. Pituitary 28:116. https://doi.org/10.1007/s11102-025-01594-1

Article  CAS  PubMed  Google Scholar 

Petersenn S, Fleseriu M, Casanueva FF et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society International Consensus Statement. Nat Rev Endocrinol 19:722–740. https://doi.org/10.1038/s41574-023-00886-5

Article  PubMed  Google Scholar 

Fleseriu M, Varlamov EV, Akirov A et al (2025) Prolactin-secreting adenomas: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 13:874–890. https://doi.org/10.1016/S2213-8587(25)00227-X

Article  CAS  PubMed  Google Scholar 

Raverot G, Ilie MD, Lasolle H, Amodru V, Trouillas J, Castinetti F, Brue T (2021) Aggressive pituitary tumours and pituitary carcinomas. Nat Rev Endocrinol 17:671–684. https://doi.org/10.1038/s41574-021-00550-w

Article  PubMed  Google Scholar 

Fernandez A, Karavitaki N, Wass JA (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72(3):377–382. https://doi.org/10.1111/j.1365-2265.2009.03667

Article  PubMed  Google Scholar 

Raappana A, Koivukangas J, Ebeling T, Pirilä T (2010) Incidence of pituitary adenomas in Northern Finland in 1992–2007. J Clin Endocrinol Metab 95(9):4268–4275. https://doi.org/10.1210/jc.2010-0537

Article  CAS  PubMed  Google Scholar 

Hamblin R, Fountas A, Lithgow K et al (2023) Natural history of non-functioning pituitary microadenomas: results from the UK non- functioning pituitary adenoma consortium. Eur J Endocrinol 189(1):87–95. https://doi.org/10.1093/ejendo/lvad070

Article  CAS  PubMed  Google Scholar 

Fountas A, Lithgow K, Loughrey PB et al (2025) Conservatively managed non-functioning pituitary macroadenomas-cohort study from the UK Non-functioning Pituitary Adenoma Consortium. Eur J Endocrinol 192(5):680–690. https://doi.org/10.1093/ejendo/lvaf091

Article  CAS  PubMed  Google Scholar 

Fleseriu M, Gurnell M, McCormack A, The Pituitary Society International Incidentaloma Consensus Group (2025) Pituitary incidentaloma: a Pituitary Society international consensus guideline statement. Nat Rev Endocrinol 21(10):638–655. https://doi.org/10.1038/s41574-025-01134-8

Article  PubMed  Google Scholar 

Koulouri O, Moran C, Halsall D, Chatterjee K, Gurnell M (2013) Pitfalls in the measurement and interpretation of thyroid function tests. Best Pract Res Clin Endocrinol Metab Dec 27(6):745–762. https://doi.org/10.1016/j.beem.2013.10.003

Article  CAS  Google Scholar 

Moran C, Schoenmakers N, Halsall D et al (2024) Approach to the Patient with Raised Thyroid Hormones and Nonsuppressed TSH. J Clin Endocrinol Metab Mar 15(4):1094–1108. https://doi.org/10.1210/clinem/dgad681

Article  CAS  Google Scholar 

Persani L, Rodien P, Moran C et al (2024) European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action. Eur Thyroid J 13(4):e240125. https://doi.org/10.1530/ETJ-24-0125

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jonklaas J (2025) The effects of levothyroxine monotherapy versus combination therapy on quality of life and patient satisfaction. Expert Rev Endocrinol Metab 20(4):317–325. https://doi.org/10.1080/17446651.2025.2492789

Article  CAS  PubMed  Google Scholar 

Millan-Alanis JM, González-González JG, Flores-Rodríguez A et al (2021) Benefits and Harms of Levothyroxine/L-Triiodothyronine Versus Levothyroxine Monotherapy for Adult Patients with Hypothyroidism: Systematic Review and Meta-Analysis. Thyroid 31(11):1613–1625. https://doi.org/10.1089/thy.2021.0270

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bahl S, Taylor PN, Premawardhana LD et al (2025) Risk of Death and Adverse Effects in Patients on Liothyronine: A Multisource Systematic Review and Meta-analysis. J Clin Endocrinol Metab 110(11):3278–3288. https://doi.org/10.1210/clinem/dgaf449

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jonklaas J, Bianco AC, Cappola AR et al (2021) Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document. Thyroid 31(2):156–182. https://doi.org/10.1089/thy.2020.0720

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Lima Beltrão FE, Carvalhal G, de Almeida Beltrão DC et al (2025) Treatment Preferences in Patients with Hypothyroidism. J Clin Endocrinol Metab Feb 18(3):887–900. https://doi.org/10.1210/clinem/dgae651

Article  CAS  Google Scholar 

Yang CC, Hsu Y, Liou JY (2021) Efficacy of Ethanol Ablation for Benign Thyroid Cysts and Predominantly Cystic Nodules: A Systematic Review and Meta-Analysis. Endocrinol Metab (Seoul) Feb 36(1):81–95. https://doi.org/10.3803/EnM.2020.833

Article  CAS  Google Scholar 

Zhao X, Xue J, Yu W et al (2025) The long-term effects of thermal ablation for benign thyroid nodules: a systematic review and meta-analysis. Eur Radiol Oct 35(10):6089–6100. https://doi.org/10.1007/s00330-025-11543-y

Article  Google Scholar 

Toraih E, Hussein M, Elshazli R et al (2025) Therapeutic outcomes and safety of radiofrequency ablation for primary papillary thyroid carcinoma: A game-changing meta-analysis. Radiother Oncol Apr 205:110706. https://doi.org/10.1016/j.radonc.2025.110706

Article  CAS  Google Scholar 

Coerts HI, D’Mello B, Verburg FA et al (2025) Thyroid Arterial Embolization for the Management of Benign and Malignant Thyroid Disease: A Systematic Review. Endocr Pract Aug 6(25):S1530–891X. https://doi.org/10.1016/j.eprac.2025.07.024

Article  Google Scholar 

Burch HB, Perros P, Bednarczuk T, Cooper DS, Dolman PJ, Leung AM, Mombaerts I, Salvi M, Stan MN (2022) Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association. Eur Thyroid J 8:e220189

Google Scholar 

https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trial-snapshot-tepezza

Salvi M (2026) What has changed in Thyroid Eye Disease in the last five years (2020–2025). Eur Thyroid J 15(1):ETJ250363. https://doi.org/10.1530/ETJ-25-0363

Article  PubMed  PubMed Central  Google Scholar 

Biscarini F, Masetti G, Muller I et al (2024) Gut Microbiome Associated With Graves’ Disease and Graves Orbitopathy: The INDIGO Multicenter European Study. J Clin Endocrinol Metab 108:2065–2077. Erratum in: J Clin Endocrinol Metab. 2024 109 e880

Shin K, Choung H, Lee MJ et al (2024) A Preliminary Evaluation of the Diagnostic Performance of a Smartphone-Based Machine Learning-Assisted System for Evaluation of Clinical Activity Score in Digital Images of Thyroid-Associated Orbitopathy. Thyroid Jun 34(6):744–752. https://doi.org/10.1089/thy.2023.0621

Article  Google Scholar 

Khan AA, Slart RHJA, Ali DS et al (2024) Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices. Mayo Clin Proc 99(7):1127–1141. https://doi.org/10.1016/j.mayocp.2024.01.011

Article  PubMed  Google Scholar 

Kanis JA, Norton N, Harvey NC et al (2021) SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16(1):82. https://doi.org/10.1007/s11657-020-00871-9

Article  PubMed  PubMed Central  Google Scholar 

Carey JJ, Chih-Hsing Wu P, Bergin D (2022) Risk assessment tools for osteoporosis and fractures in 2022. Best Pract Res Clin Rheumatol 36(3):101775. https://doi.org/10.1016/j.berh.2022.101775

Article  PubMed  Google Scholar 

Pencina MJ, Goldstein BA, D’Agostino RB (2020) Prediction Models – Development, Evaluation, and Clinical Application. N Engl J Med 382(17):1583–1586. https://doi.org/10.1056/NEJMp2000589

Article